Silibinin as a promising treatment for diabetes: Insights into behavioral and metabolic changes in an animal model
- PMID: 38726421
- PMCID: PMC11077243
- DOI: 10.1002/fsn3.3999
Silibinin as a promising treatment for diabetes: Insights into behavioral and metabolic changes in an animal model
Abstract
Diabetes mellitus is causing serious health problems in the chronic period. Silibinin is a flavonoid obtained from the milk thistle (Silybum marianum), which is among the herbal ethnopharmacological administrations. In studies with silibinin, it has been reported that it increases the activity of pancreatic beta cells and insulin sensitivity and has a hyperglycemia-reducing effect. However, behavioral parameters have not been evaluated together with insulin levels and liver function tests. Our aim in this study was to examine the effects of silibinin on insulin secretion, anxiety-like behaviors, and learning in a streptozotocin (STZ)-induced rat diabetes model. Wistar albino rats weighing 200-250 g were divided into 4 groups. Control: Saline solution, Diabetes: STZ 45 mg/kg, S 100: STZ 45 mg/kg + Silibinin 100 mg/kg, S 200: STZ 45 mg/kg + Silibinin 200 mg/kg. Administrations were continued for 21 days. On the 21st day, open field and elevated plus maze as unconditional anxiety tests; Barnes maze for learning and memory; and rotarod test for locomotor activity were conducted. Following behavioral tests, blood samples were taken under anesthesia. Blood glucose levels and ALT values were measured. Insulin levels were measured with an ELISA plate reader. Silibinin shortened the time to find the correct hole. Silibinin prevented the decrease in insulin due to STZ, exhibited a hyperglycemia-reducing effect and decreased the elevation of ALT.
Keywords: behavior; diabetes mellitus; insulin; silibinin; streptozotocin.
© 2024 The Authors. Food Science & Nutrition published by Wiley Periodicals LLC.
Figures
![FIGURE 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/11077243/bin/FSN3-12-3336-g010.gif)
![FIGURE 2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/11077243/bin/FSN3-12-3336-g004.gif)
![FIGURE 3](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/11077243/bin/FSN3-12-3336-g005.gif)
![FIGURE 4](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/11077243/bin/FSN3-12-3336-g009.gif)
![FIGURE 5](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/11077243/bin/FSN3-12-3336-g012.gif)
![FIGURE 6](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/11077243/bin/FSN3-12-3336-g008.gif)
![FIGURE 7](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/11077243/bin/FSN3-12-3336-g007.gif)
![FIGURE 8](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/11077243/bin/FSN3-12-3336-g002.gif)
![FIGURE 9](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/11077243/bin/FSN3-12-3336-g003.gif)
![FIGURE 10](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/11077243/bin/FSN3-12-3336-g013.gif)
![FIGURE 11](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/11077243/bin/FSN3-12-3336-g011.gif)
![FIGURE 12](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/11077243/bin/FSN3-12-3336-g006.gif)
Similar articles
-
Silibinin ameliorates STZ-induced impairment of memory and learning by up- regulating insulin signaling pathway and attenuating apoptosis.Physiol Behav. 2020 Jan 1;213:112689. doi: 10.1016/j.physbeh.2019.112689. Epub 2019 Oct 25. Physiol Behav. 2020. PMID: 31669775
-
Inhibition of GluN2B pathway is involved in the neuroprotective effect of silibinin on streptozotocin-induced Alzheimer's disease models.Phytomedicine. 2023 Jan;109:154594. doi: 10.1016/j.phymed.2022.154594. Epub 2022 Dec 10. Phytomedicine. 2023. PMID: 36610115
-
Effects of silibinin on apoptosis and insulin secretion in rat RINm5F pancreatic β-cells.Biotech Histochem. 2023 Apr;98(3):201-209. doi: 10.1080/10520295.2022.2154840. Epub 2023 Feb 10. Biotech Histochem. 2023. PMID: 36762428
-
Silibinin decreases hepatic glucose production through the activation of gut-brain-liver axis in diabetic rats.Food Funct. 2018 Sep 19;9(9):4926-4935. doi: 10.1039/c8fo00565f. Food Funct. 2018. PMID: 30178798
-
Silibinin as a major component of milk thistle seed provides promising influences against diabetes and its complications: a systematic review.Naunyn Schmiedebergs Arch Pharmacol. 2024 May 27. doi: 10.1007/s00210-024-03172-x. Online ahead of print. Naunyn Schmiedebergs Arch Pharmacol. 2024. PMID: 38801454 Review.
References
-
- Amiri, S. , & Behnezhad, S. (2019). Diabetes and anxiety symptoms: A systematic review and meta‐analysis. The International Journal of Psychiatry in Medicine, 54, 91217419837407. - PubMed
-
- Chen, K. , Xu, J. , He, H. , Zhao, L. , Xiong, J. , & Mo, Z. (2015). Protective effect of silibinin on islet β cells in C57BL/6J mice fed a highfat diet. Zhong Nan Da Xue Xue Bao. Yi Xue Ban, 40, 165–170. - PubMed
-
- Chen, K. , Zhao, L. , He, H. , Wan, X. , Wang, F. , & Mo, Z. (2014). Silibinin protects β cells from glucotoxicity through regulation of the Insig‐1/SREBP‐1c pathway. International Journal of Molecular Medicine, 34(4), 1073–1080. - PubMed
-
- Chu, C. , Li, D. , Zhang, S. , Ikejima, T. , Jia, Y. , Wang, D. , & Xu, F. (2018). Role of silibinin in the management of diabetes mellitus and its complications. Archives of Pharmacal Research, 41(8), 785–796. - PubMed
LinkOut - more resources
Full Text Sources